Determining when an infectious disease outbreak can be declared over safely is a critical challenge for public health policy advisors.
Although end-of-outbreak declarations permit the relaxation of control measures, premature declarations risk subsequent disease resurgence.
As a result, there has been increasing interest in developing quantitative frameworks for real-time estimation of the probability that additional cases will occur.
These approaches can be applied towards the end of an outbreak, following the apparent final reported case, to determine the risk associated with declaring the outbreak over.
I will present several mathematical modelling approaches for assessing the probability that additional cases will occur at the apparent end of an outbreak.
First, I will describe a method based on stochastic compartmental models, in which repeated model simulation can be used to derive practical “rules of thumb” for the minimum waiting time without cases required before declaring an outbreak over.
Second, I will present an exact probabilistic framework based on stochastic branching process models, in which disease incidence time series data are combined with contact tracing information to calculate the probability of additional cases.
I will also show how this framework can be extended to settings in which contact tracing data are unavailable. Finally, I will discuss a renewal equation based approach for estimating the probability of additional cases directly from disease incidence time series data.
This flexible framework was applied in the context of the 2017 Ebola outbreak in the Democratic Republic of the Congo to assess when interventions could be relaxed safely.
Together, the methods presented provide a rigorous quantitative basis for informing public health decision making at the end of an infectious disease outbreak.
Lucija Krce and Marcela Mandarić
University of Split
BioFIDE project: From Bacterial Imaging to Topological Data Analysis
View abstract
The BioFIDE project connects research on bioactive molecules and nanomaterials with mathematical analysis of biological systems. Here, we address a practical question:
how can microscopy images be used to quantify bacterial responses to antibacterial treatment?
Lucija Krce, principal investigator of bioFIDE, will introduce the project and present efforts to develop a relatively simple procedure for preparing bacterial cells for scanning electron microscopy.
Using conventional and alternative imaging modes, we compare untreated Escherichia coli and Staphylococcus aureus cells with cells exposed to an antibacterial surfactant belonging to the quaternary ammonium compounds—a class widely used in disinfectants.
Building on these experiments, Marcela Mandarić will present an approach that assesses cell shape and uses topological data analysis to examine bacterial surface texture.
Persistent homology describes features of the bacterial surface that are not captured by cell outlines alone.
Statistical tests assess differences between treated and untreated cells.
The study illustrates how experimental imaging and mathematical methods can be combined to move beyond visual inspection towards a quantitative description of treatment-associated changes in bacterial morphology.
Abbie Evans
University of Oxford
Estimating how outbreak dynamics and intervention outcomes are shaped by different heterogeneity types
Mathematical epidemiology. Title and abstract coming soon.
Janoš Terzić
University of Split
Contribution of gut bacteria to urinary bladder cancer
View abstract
Exposure to environmental pollutants and the composition of the
human microbiota may influence the risk of cancer. Like drugs,
pollutants are metabolized in the body, which can alter their
carcinogenic effects and where they reach in tissues. Although gut
microorganisms can transform many chemicals and affect their
metabolism, their role in pollutant-induced cancer remains
unclear. We showed that reducing gut bacteria changes the
metabolism of cigarette smoke-associated nitrosamines and
substantially decreases the development and severity of
nitrosamine-induced bladder cancer in mice. Using bacterial
isolates, human gut microbial communities, and mouse models, we
identified specific bacteria that contribute to this carcinogen
metabolism. We also found that this activity varies between
individuals and applies to several related nitrosamine
carcinogens. These findings suggest that gut microbiota can
influence how environmental chemicals contribute to cancer
development. Understanding these interactions could help improve
cancer risk assessment and identify new microbiome-based
approaches for cancer prevention.